Anxiety disorders - a common problem about which we still don’t know enough
DOI:
https://doi.org/10.12775/JEHS.2023.46.01.017Keywords
anxiety, anxiety disorders, drug treatment, psychotherapyAbstract
Anxiety disorders are the most common mental disorders. Up to one-third of the population suffers from them during their lifetime. An important problem is also the lack of awareness of patients about their disease. Only half of the anxiety disorders are diagnosed. Only a fifth of people suffering from anxiety disorders sought help from a specialist doctor. Only a third of patients are offered pharmacological treatment. The main symptom of this disease is an increased and intense feeling of anxiety. It is also associated with many other physical symptoms. It is correlative with a reduced quality of life and functioning in society. Diagnosis of anxiety disorders is very difficult due to the lack of specific imaging and laboratory tests that may be helpful in making or suggest a diagnosis. There is also a correlation between these disorders and the occurrence of depressive disorders, which is why the problem is complex and requires increased diagnostic sensitivity. Worldwide, anxiety disorders are underdiagnosed and undertreated, that's why it's so important to be aware of this disease entity. Prompt intervention by a physician is very important due to the increased frequency of suicides. The basic treatment is medication therapy with drugs from the SSRI and SNRI group combined with cognitive-behavioral therapy. Quick diagnosis and implementation of treatment contributes to a significant improvement in the quality of life of patients.
References
R. C. Kessler, M. Petukhova, N. A. Sampson, A. M. Zaslavsky, and H. U. Wittchen, “Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States,” Int J Methods Psychiatr Res, vol. 21, no. 3, pp. 169–184, Sep. 2012, doi: 10.1002/MPR.1359.
A. Ströhle, J. Gensichen, and K. Domschke, “The Diagnosis and Treatment of Anxiety Disorders,” Dtsch Arztebl Int, vol. 115, no. 37, p. 611, Sep. 2018, doi: 10.3238/ARZTEBL.2018.0611.
T. L. Barrera and P. J. Norton, “Quality of life impairment in generalized anxiety disorder, social phobia, and panic disorder,” J Anxiety Disord, vol. 23, no. 8, pp. 1086–1090, Dec. 2009, doi: 10.1016/J.JANXDIS.2009.07.011.
B. O. Olatunji, J. M. Cisler, and D. F. Tolin, “Quality of life in the anxiety disorders: A meta-analytic review,” Clin Psychol Rev, vol. 27, no. 5, pp. 572–581, Jun. 2007, doi: 10.1016/J.CPR.2007.01.015.
“Phenomenology and epidemiology of panic disorder-Web of Science Core Collection.” https://www.webofscience.com/wos/woscc/full-record/WOS:000269980700006?SID=EUW1ED0C3C2htpoiiURrl0yZ2o0a3 (accessed Mar. 11, 2023).
F. Thibaut, “Anxiety disorders: a review of current literature,” Dialogues Clin Neurosci, vol. 19, no. 2, p. 87, 2017, doi: 10.31887/DCNS.2017.19.2/FTHIBAUT.
K. Beesdo, D. S. Pine, R. Lieb, and H. U. Wittchen, “Incidence and risk patterns of anxiety and depressive disorders and categorization of generalized anxiety disorder,” Arch Gen Psychiatry, vol. 67, no. 1, pp. 47–57, Jan. 2010, doi: 10.1001/ARCHGENPSYCHIATRY.2009.177.
B. Bandelow and S. Michaelis, “Epidemiology of anxiety disorders in the 21st century,” Dialogues Clin Neurosci, vol. 17, no. 3, p. 327, 2015, doi: 10.31887/DCNS.2015.17.3/BBANDELOW.
R. C. Kessler, P. Berglund, O. Demler, R. Jin, K. R. Merikangas, and E. E. Walters, “Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication,” Arch Gen Psychiatry, vol. 62, no. 6, pp. 593–602, Jun. 2005, doi: 10.1001/ARCHPSYC.62.6.593.
G. Rubio and J. J. López-Ibor, “What can be learnt from the natural history of anxiety disorders?,” European Psychiatry, vol. 22, no. 2, pp. 80–86, Mar. 2007, doi: 10.1016/J.EURPSY.2006.09.007.
G. Rubio and J. J. López-Ibor, “Generalized anxiety disorder: a 40-year follow-up study,” Acta Psychiatr Scand, vol. 115, no. 5, pp. 372–379, May 2007, doi: 10.1111/J.1600-0447.2006.00896.X.
B. Bandelow, S. Michaelis, and D. Wedekind, “Treatment of anxiety disorders,” Dialogues Clin Neurosci, vol. 19, no. 2, p. 93, Jun. 2017, doi: 10.31887/DCNS.2017.19.2/BBANDELOW.
M. G. Gottschalk and K. Domschke, “Novel developments in genetic and epigenetic mechanisms of anxiety,” Curr Opin Psychiatry, vol. 29, no. 1, pp. 32–38, 2016, doi: 10.1097/YCO.0000000000000219.
K. Beesdo, S. Knappe, and D. S. Pine, “Anxiety and Anxiety Disorders in Children and Adolescents: Developmental Issues and Implications for DSM-V,” Psychiatr Clin North Am, vol. 32, no. 3, p. 483, Sep. 2009, doi: 10.1016/J.PSC.2009.06.002.
K. Domschke, B. Klauke, J. Deckert, A. Reif, and P. Pauli, “Life events in panic disorder-an update on ‘candidate stressors,’” Depress Anxiety, vol. 27, no. 8, pp. 716–730, Aug. 2010, doi: 10.1002/DA.20667.
T. Dresler et al., “Revise the revised? New dimensions of the neuroanatomical hypothesis of panic disorder,” Journal of Neural Transmission 2012 120:1, vol. 120, no. 1, pp. 3–29, Jun. 2012, doi: 10.1007/S00702-012-0811-1.
B. Bandelow, T. Lichte, S. Rudolf, J. Wiltink, and M. E. Beutel, “The German guidelines for the treatment of anxiety disorders,” Eur Arch Psychiatry Clin Neurosci, vol. 265, no. 5, pp. 363–373, Aug. 2015, doi: 10.1007/S00406-014-0563-Z/TABLES/5.
F. Jacobi et al., “[Mental disorders in the general population : Study on the health of adults in Germany and the additional module mental health (DEGS1-MH)],” Nervenarzt, vol. 85, no. 1, pp. 77–87, Jan. 2014, doi: 10.1007/S00115-013-3961-Y.
R. C. Kessler et al., “Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey,” Arch Gen Psychiatry, vol. 51, no. 1, pp. 8–19, 1994, doi: 10.1001/ARCHPSYC.1994.03950010008002.
B. W. Penninx, D. S. Pine, E. A. Holmes, and A. Reif, “Anxiety disorders,” Lancet, vol. 397, no. 10277, p. 914, Mar. 2021, doi: 10.1016/S0140-6736(21)00359-7.
M. R. Liebowitz, “Social phobia,” Mod Probl Pharmacopsychiatry, vol. 22, pp. 141–173, 1987, doi: 10.1159/000414022.
M. HAMILTON, “The assessment of anxiety states by rating,” Br J Med Psychol, vol. 32, no. 1, pp. 50–55, 1959, doi: 10.1111/J.2044-8341.1959.TB00467.X.
J. Alonso et al., “Treatment Gap for Anxiety Disorders is Global: Results of the World Mental Health Surveys in 21 countries HHS Public Access,” Depress Anxiety, vol. 35, no. 3, pp. 195–208, 2018, doi: 10.1002/da.22711.
M. B. Stein et al., “Quality of and Patient Satisfaction With Primary Health Care for Anxiety Disorders,” J Clin Psychiatry, vol. 72, no. 7, p. 16474, Feb. 2011, doi: 10.4088/JCP.09M05626BLU.
A. T. Gloster et al., “Psychological treatment for panic disorder with agoraphobia: a randomized controlled trial to examine the role of therapist-guided exposure in situ in CBT,” J Consult Clin Psychol, vol. 79, no. 3, pp. 406–420, Jun. 2011, doi: 10.1037/A0023584.
A. N. Kaczkurkin and E. B. Foa, “Cognitive-behavioral therapy for anxiety disorders: an update on the empirical evidence,” Dialogues Clin Neurosci, vol. 17, no. 3, pp. 337–346, 2015, doi: 10.31887/DCNS.2015.17.3/AKACZKURKIN.
B. Bandelow, M. Reitt, C. Röver, S. Michaelis, Y. Görlich, and D. Wedekind, “Efficacy of treatments for anxiety disorders: a meta-analysis,” Int Clin Psychopharmacol, vol. 30, no. 4, pp. 183–192, Jun. 2015, doi: 10.1097/YIC.0000000000000078.
A. Ströhle, “Sports psychiatry: mental health and mental disorders in athletes and exercise treatment of mental disorders,” Eur Arch Psychiatry Clin Neurosci, vol. 269, no. 5, pp. 485–498, Aug. 2019, doi: 10.1007/S00406-018-0891-5.
B. F. Grant et al., “Epidemiology of DSM-5 Alcohol Use Disorder: Results From the National Epidemiologic Survey on Alcohol and Related Conditions III,” JAMA Psychiatry, vol. 72, no. 8, pp. 757–766, Aug. 2015, doi: 10.1001/JAMAPSYCHIATRY.2015.0584.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Kamila Giżewska, Karol Lorenc, Olga Bielawska, Tomasz Łoś, Michał Kuc, Maciej Rogala, Klaudia Jabłońska, Marta Gulbicka
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 974
Number of citations: 0